- Home
- MREO vs CIO Comparison
MREO vs CIO Comparison
Compare MREO & CIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- CIO
- Stock Information
- Founded
- MREO 2015
- CIO 2013
- Country
- MREO United Kingdom
- CIO Canada
- Employees
- MREO N/A
- CIO N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- CIO Real Estate Investment Trusts
- Sector
- MREO Health Care
- CIO Real Estate
- Exchange
- MREO Nasdaq
- CIO Nasdaq
- Market Cap
- MREO 311.8M
- CIO 278.5M
- IPO Year
- MREO N/A
- CIO 2014
- Fundamental
- Price
- MREO $1.84
- CIO $6.92
- Analyst Decision
- MREO Strong Buy
- CIO Hold
- Analyst Count
- MREO 5
- CIO 1
- Target Price
- MREO $7.40
- CIO N/A
- AVG Volume (30 Days)
- MREO 1.6M
- CIO 317.8K
- Earning Date
- MREO 11-10-2025
- CIO 11-06-2025
- Dividend Yield
- MREO N/A
- CIO 5.78%
- EPS Growth
- MREO N/A
- CIO N/A
- EPS
- MREO N/A
- CIO N/A
- Revenue
- MREO $500,000.00
- CIO $163,795,000.00
- Revenue This Year
- MREO N/A
- CIO $0.32
- Revenue Next Year
- MREO $72.16
- CIO $3.20
- P/E Ratio
- MREO N/A
- CIO N/A
- Revenue Growth
- MREO N/A
- CIO N/A
- 52 Week Low
- MREO $1.47
- CIO $4.19
- 52 Week High
- MREO $4.29
- CIO $7.01
- Technical
- Relative Strength Index (RSI)
- MREO 45.03
- CIO 48.93
- Support Level
- MREO $1.65
- CIO $6.87
- Resistance Level
- MREO $1.93
- CIO $6.93
- Average True Range (ATR)
- MREO 0.12
- CIO 0.02
- MACD
- MREO -0.02
- CIO -0.00
- Stochastic Oscillator
- MREO 36.00
- CIO 71.43
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About CIO City Office REIT Inc.
City Office REIT Inc is a real estate investment trust. It is focused on acquiring, owning, and operating high-quality office properties located predominantly in Sun Belt markets. The principal objective of the company is to provide attractive risk-adjusted returns to its investors over the long-term through a combination of dividends and capital appreciation. Its properties includes: Pima Center, SanTan, Park Tower, Intellicenter, Intellicenter, Denver Tech, Canyon Park, AmberGlen and many. The company own these office buildings in the metropolitan areas of Dallas, Denver, Orlando, Phoenix, Portland, Raleigh, San Diego, Seattle, and Tampa.